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Introduction 
Sustained release matrix dosage forms are designed to 
achieve a prolonged therapeutic action by continuous 
releasing medication over an extended period of time 
after administration of single dose. In order to achieve 
steady level of medication, biodegradable polymer may 
play  a  vital  role  due  to  their  biodegradability.
1 
Sustained  drug  delivery  involves  the  application  of 
physical  and  polymer  chemistry  to  produce  well 
characterized  and  reproducible  dosage  forms,  which 
control  drug  entry  into  the  body  within  the 
specifications of the required drug delivery profile. A 
sustained  release  dosage  forms  allows  a  twofold  or 
greater reduction in frequency of administration of the 
drug  in  comparison  with  frequency  required  by  a 
conventional  dosage  forms.
2  Typically,  sustained 
release products provide an immediate release of drug 
that promptly produces the desired therapeutic effect, 
followed by gradual release of additional amounts of 
drug  to  maintain  this  effect  over  a  predetermined 
period. In this type of dosage forms, the rate of drug 
release mainly controlled by the delivery system itself, 
though it may be influenced by external conditions, like 
pH,  enzymes,  ions,  motility  and  physiological 
conditions.
3  A  wide  array  of  polymers  has  been 
employed as retarding agents each of which presents a 
different approach to the matrix concept. Polymers that 
primarily  forming  insoluble  of  skeleton  matrices  are 
considered as the first category of retarding materials 
are  classified  as  plastic  matrix  systems.  The  second 
class  represents  hydrophobic  and  water-insoluble 
materials, which are potentially erodible and the third 
group  behaves  hydrophilic  properties.  Plastic  matrix 
systems,  due  to  their  chemical  inertness  and  drug 
embedding  ability,  have  been  widely  used  for 
sustaining the release of drug. Liquid penetration into 
the  matrix  is  the  rate  limiting  step  in  such  systems 
unless  channeling  agents  are  used.  The  hydrophobic 
and waxy materials, on the other hand, are potentially 
erodible and control the release of drug through pore 
diffusing  and  erosion.
2 The  drug  release  from  matrix 
tablet  depends  on  other  factors  such  as  pore 
permeability, shape and size of matrix, drug solubility, 
polymer molecular weight, drug loading, compression 
force, and hydrodynamic conditions.
4 Previous studies 
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Purpose: The present study was explored to develop a sustained release matrix tablet of 
Indapamide,  a  low-dose  thiazide-type  diuretic,  using  hydroxylpropyl  methylcellulose 
(Methocel K15MCR) in various proportions as release controlling factor. 
Methods: The tablets were formulated using direct compression method. The powers for 
tableting were evaluated for angle of response, loose bulk density, tapped bulk density, 
compressibility index, total porosity and drug content etc. The tablets were subjected to 
thickness,  weight  variation  test,  drug  content,  hardness,  friability,  and  in  vitro 
dissolution studies. 
Results: The granules showed satisfactory flow properties, compressibility index, and 
drug  content.  All  the  formulated  tablets  complies  pharmacopoeia  specifications.  The 
release  kinetics  of  the  drug  decreased  exponentially  with  the  addition  of  polymer 
concentration. Indapamide release rate was observed to be the highest with the lowest 
concentration of polymer used. The release mechanism was explored with zero order, 
first  order,  Higuchi  and  Krosmeyer  equations.  Stability  tests  of  the  drug  showed  no 
notable changes in the rate of drug release, related substances and drug content. 
Conclusion: In the context, it can be suggested that this formulation of sustained release 
Indapamide tablets can be marketed to treat patients with hypertension ensuring proper 
healthcare.  
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developed by Williams et al.
5 led to the conclusion that 
the type and level of excipients influence the rate and 
extension of drug release.  
Indapamide  is  an  orally  active  sulphonamide  diuretic 
agent. Although some evidence appears to indicate that 
the antihypertensive action of indapamide is primarily a 
result  of  its  diuretic  activity,  only  a  limited  diuresis 
occurs with the usual antihypertensive doses of 2.5 mg 
daily, and in vitro and in vivo data suggest that it may 
also  reduce  blood  pressure  by  decreasing  vascular 
reactivity and peripheral vascular resistance. In mild to 
moderate  hypertension  it  is  as  effective  as  thiazide 
diuretics and β -adrenergic blocking agents in lowering 
blood  pressure  when  used  as  the  sole  treatment.
6 
Indapamide has  been successfully  combined with  β  -
adrenergic  blocking  agents,  methyldopa,  and  other 
antihypertensive  agents.  While  such  findings  need 
confirmation,  it  appears  that  indapamide  shares  the 
potential with other diuretic agents to induce electrolyte 
and other metabolic abnormalities, although it may do 
so with less frequency or severity.
6 The main purpose 
of our present study was to formulate sustained release 
matrix  tablet  of  Indapamide  using  hydroxypropyl 
methylcellulose  (Methocel
1)  and  evaluate  its  quality 
and release profile as well to justify the formulation. 
 
Materials and Methods 
Materials  
The  ingredients  and  the  equipments  used  in  the 
formulations  are  mentioned  in  Table  1  and  Table  2 
respectively. 
 
Table 1. List of active ingredient and other excipients used in 
the preparation of matrix tablets 
Name  Category  Source 
Indapamide  Active Ingredient  Merck, Germany 
Methocel K15M CR  Matrix forming agent  Colorcon, USA 
Lactose  Diluent  Colorcon, USA 
Talc  Lubricant  Colorcon, USA 
Magnesium stearate  Antiadherent  Colorcon, USA 
Aerosil  Flow promotor  Colorcon, USA 
 
Table 2. List of equipments used in the method of Indapamide 
SR tablets 
 
Methods 
Preparation of Matrix Tablet: Indapamide 
The  tablets  were  prepared  by  direct  compression 
method. In all the formulations (Table 3), the weight of 
the active is 2.5 mg and the total weight of the tablet is 
200  mg.  At  first  all  the  ingredients  along  with  the 
active were measured appropriately and carefully. The 
initial stage of the preparation was mixing. The active 
ingredient,  matrix  forming  polymer  Methocel  K15M 
CR and the filler or diluents lactose were mixed well. 
The next step was milling of the mixed ingredients. At 
the last stage of the method, microcrystalline cellulose, 
magnesium  stearate  and  aerosil  were  added  to  the 
formulation. The tablets were prepared by compressing 
the tablets in using 5 punch compression machine with 
a  15.00×7.00  mm  round  punch  and  die  set.  The 
compression force was 10 ton. Before the compression 
the  face  of  the  die  and  punch  were  lubricated  with 
purified talc. 
 
Table 3. Formulation of Indapamide sustained release tablet. 
Ingradients 
F1 
mg 
F2 
mg 
F3 
mg 
F4 
mg 
F5 
mg 
Indapamide  2.5  2.5  2.5  2.5  2.5 
Methocel K15MCR  20  40  60  80  100 
Aerosil  3.0  3.0  3.0  3.0  3.0 
Microcrystalline 
Cellulose 
4  4  4  4  4 
Magnesium 
stearate  3.5  3.5  3.5  3.5  3.5 
Lactose 
Monohydrate 
167.0  147.0  127.0  107.0  87.0 
 
Physical Characterization of Indapamide Tablets  
Length, Width, Size and Shape: The length and width 
of tablets depends on the die and punches selected for 
making  the  tablets.  The  tablets  of  various  sizes  and 
shapes are prepared but generally they are circular with 
either flat or biconvex faces. Here we prepared round 
cylindrical shape tablets. 
Thickness: The thickness of a tablet can vary without 
any change in its weight. This is generally due to the 
difference of density of granules, pressure applied for 
compression  and  the  speed  of  compression.  The 
thickness  of  the  tablets  was  determined  by  using  a 
Digital Caliper (range 0-150 mm). 
Uniformity  of  Weight:  It  is  desirable  that  every 
individual tablet in a batch should be in uniform weight 
and weight variation within permissible limits. If any 
weight  variation  is  there,  that  should  fall  within  the 
prescribed limits (generally ±10% for tablets weighing 
130 mg or less, ±7.5% for tablets weighing 130 to 324 
mg and ±5% for tablets weighing more than 324 mg).
7 
The weights of 10 tablets of each batch were taken at 
individually  and  calculate  the  average  weight  of  10 
tablets.  The  weights  were  determined  by  using  an 
electronic balance. Then we determined the percentage 
of weight variation of each tablet by using following 
formula. 
Name  Model  Source  Country 
Sieve  - 
Endecotts, 
Test Sieve 
UK 
Compression Machine   Manesty D type  -  UK 
Electronic Balance  AR2140  OHAIS  Switzerland 
Digital pH meter  pH 209  HANNA  Romania 
Shaker 
Power Sonic 
505 
Hwashin 
Technology 
South 
Korea 
Hardness tester  EH-01P  Electro Lab  India 
Fribilator  EF-2  Electro Lab  India 
Dissolution Tester  TDT-08L Plus  Electro Lab  India 
UV-Spectrophotometer  UV-1800 
SHIMADZU 
Corporation 
Japan  
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Percentage of weight variation= [(Average weight – 
Individual weight)/ Average wt.] ×100 
Friability: Friability test was performed to evaluate the 
ability of the tablets to withstand abrasion in packing, 
handling and transporting. The instrument used for this 
test  is  known  as  ‘Friability  Test  Apparatus’  or 
‘Friabilator’. Friability of the tablets was determined by 
using  Electrolab,  EF-2  friability  test  apparatus.  It 
consists of a plastic chamber which is divided into two 
parts and revolves at a speed of 25 rpm. A number of 
tablets were weighed (W1) and placed in the tumbling 
chamber which was rotated for four minutes or for 100 
revolutions. During each revolution the tablets fall from 
a distance of six inches to undergo shock. After 100 
revolutions  the  tablets  were  again  weighed  (W2)  and 
the  loss  in  weight  indicates  the  friability.  The 
acceptable limits of weights loss should not be  more 
than 1 percent.
8 
Friability = {(W1 – W2)/W1} × 100 
Hardness: The hardness of tablet depends on the weight 
of  the  material  used,  space  between  the  upper  and 
lower punches at the time of compression and pressure 
applied during compression. The hardness also depends 
on  the  nature  and  quantity  of  excipients  used  during 
compression.  The  hardness  of  the  tablets  was 
determined  by  using  a  hand  operated  hardness  tester 
apparatus  (Electrolab,  EH-01P).  A  tablet  hardness  of 
about  6-8  kg-ft  was  considered  for  mechanical 
stability.
7 If the finished tablet is too hard, it may not 
disintegrate in the required period  of time and if  the 
tablet  is  too  soft  it  may  not  withstand  the  handling 
during  packing  and  transporting.  Therefore  it  is  very 
necessary to check the hardness of tablets when they 
are  being  compressed  and  pressure  adjusted 
accordingly on the tablet machine. 
 
Assay of Indapamide 
Preparation of Sample Solution: At first, 10 tablets of 
indapamide  SR  tablets  from  each  formulation  were 
weighed accurately and were grinded to a fine powder. 
Then  20  mg  of  powder  was  taken  in  a  100  ml 
volumetric flask and diluted with phosphate buffer up 
to the mark. Then 1ml solution was taken into another 
100ml volumetric flask and diluted with buffer up to 
the mark. Then their absorbance was measured at 242 
nm using a UV spectrophotometer (UV- 1800, UV-VIS 
spectrophotometer, Shimadzu, Japan). 
Then the percentage of potency was calculated by the 
following equation: 
              
                                   
                                 
 
Where, 
Aspl =Absorbance of Sample 
Wstd =Weight of Standard    
Pstd =Potency of standard   
Astd = Absorbance of standard 
Wspl =Weight of sample 
 
Dissolution  Procedure:  Dissolution  studies  were 
conducted by  USP  type II  test  apparatus  (Electrolab, 
TDL-80L  Plus,  India)  at  a  speed  of  50  rpm  and  the 
temperature was maintained at 37° ± 0.5°C. 
This operation was continued for 8 hours. At every 1-
hour interval samples of 6 ml were withdrawn from the 
dissolution medium and replaced with fresh dissolution 
medium  to  maintain  the  volume  constant.  After 
filtration and appropriate dilution, the sample solution 
was  analyzed  at  242  nm  for  indapamide  by  UV 
spectrophotometer. The amounts of the drug present in 
the sample were calculated with the help of straight line 
equation  obtained  from  the  standard  curve  for  the 
drugs.  The  dissolution  study  was  continued  to  get  a 
simulated  picture  of  the  drug  release  in  the  in  vivo 
condition and drug dissolved at specified time periods 
was plotted as percent release versus time (h) curves. 
This  drug  release  profile  was  fitted  into  several 
mathematical  models  to  get  an  idea  of  the  release 
mechanism of the drug from the dosage form. 
 
Analysis of Release Data 
The  release  data  obtained  were  treated  according  to 
zero-order (cumulative amount of drug release versus 
time),  first  order  (log  cumulative  percentage  of  drug 
remaining  versus  time),  Higuchi  (cumulative 
percentage of drug release versus square root of time), 
and Korsmeyer-Peppas (log cumulative percentage of 
drug release versus log time) equation models. 
Dissolution data were also fitted according to the well-
known  exponential  equation,  which  is  often  used  to 
describe  the  drug  release  behavior  from  polymeric 
systems introduced by Korsmeyer-Peppas et al.
9  
Mt / M∞ = k t
n 
Where, Mt is the amount of drug release at time t, M∞ is 
the amount of drug  release after infinite  time; k is  a 
release  rate  constant  incorporating  structural  and 
geometric  characteristics  of  the  tablet  and  n  is  the 
diffusion exponent indicative of the mechanism of drug 
release. A value of n = 0.45 indicates Fickian (case I) 
release, > 0.45 but < 0.89 for non-Fickian (anomalous) 
release  and  >  0.89  indicates  super  case  II  type  of 
release. Case II generally refers to the erosion of the 
polymeric chain and anomalous transport (non-Fickian) 
refers to a combination of both diffusion and erosion 
controlled-drug release.
2 Mean dissolution time (MDT) 
was  calculated  from  dissolution  data  using  the 
following equation.
2 
MDT = (n/n+1) k 
- 1/n 
Where, n=release exponent and k= release rate constant 
 
Results and Discussion 
Drug Content and Physical Evaluation of Indapamide 
Matrix Tablets 
After preparing the matrix tablets, all the tablets of the 
proposed  formulations  were  subjected  to  various 
evaluation tests such as hardness, thickness, uniformity 
of weight, drug content and friability (Table 4). 
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Table 4. Physical properties of Indapamide 
Formulations  Weight variations (mg)±SEM  Hardness (kg/cm
2
)±SEM  Thickness (mm)  Friability (%)  Drug content (%) 
F 1  200.45 ± 0.98  6.5 ± 0.21  4.2 ± 0.05  0.03  99.0 ± 1.2 
F 2  200.51 ± 1.1  7.1 ± 0.35  4.3 ± 0.04  0.04  101.12 ± 0.97 
F 3  200.43 ±1.3  7.9 ± 0.65  4.5 ± 0.04  0.02  99.23 ± 0.27 
F 4  201.3± 0.95  8.1 ± 0.24  4.4 ± 0.03  0.03  100.52 ± 0.86 
F 5  201.7 ± 1.12  8.0 ± 0.37  4.2 ± 0.04  0.02  98.33 ± 0.96 
Here, n=10; SEM= Standard Error Mean 
 
Polymeric Effect on Formulated Indapamide Tablets 
For  this  study  different  matrix  tablets  containing 
Indapamide  as  active  ingredient  and  Methocel 
K15MCR  as  the  rate  retarding  polymer  were 
prepared.  The  polymer  concentrations  were  10%, 
20%, 30%, 40%, and 50% of the total tablet weight 
having the formulation codes F1, F2, F3, F4, and F5 
respectively.  After  preparing  the  tablets  the 
dissolution studies were conducted in paddle method 
at  a  speed  of  50  rpm  and  the  temperature  was 
maintained  at  37°  ±  0.5°C.  This  operation  was 
continued  for  8  hours.  Three  tablets  from  each 
formulation were taken  for the test.  In vitro  release 
kinetics and mechanisms are explained by zero order, 
first  order,  higuchi  and  korsmeyer  models.  The 
highest Methocel K15MCR containing formulation F5 
showed  the  highest  MDT  and  t50  value  which 
indicates  the  rate  retarding  effect  of  Methocel 
K15MCR (Table 5). From Figure 1- 4, we can see the 
zero order, first order, Higuchi and Korsmeyer-Peppas 
release kinetics of the formulated drugs respectively. 
 
Table 5. MDT and t50 value of the drug Indapamide 
Formulation  t50 (hr)  MDT 
F1  5.6663  4.67745 
F2  8.6633  6.637662 
F3  12.7643  11.63254 
F4  15.754  14.76884 
F5  23.6574  21.65762 
 
 
Figure 1. Zero order release kinetics of Indapamide from 
Methocel K15MCR matrices 
 
 
Figure 2. First order release kinetics of Indapamide from 
Methocel K15MCR matrices 
 
 
Figure 3. Higuchi release kinetics of Indapamide from 
Methocel K15MCR matrices 
 
 
Figure 4. Korsmeyer- Peppas release kinetics of Indapamide 
from Methocel K15MCR matrices  
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Conclusion 
The study reveals that it is possible to design sustained 
release  solid  dosage  form  with  Methocel  K15MCR 
polymer.  The  polymers  which  were  used  in  the 
formulations  seem  to  be  satisfactory  for  sustained 
release  properties.  The  polymeric  effects  on  the 
formulated tablets are evident. The MDT and t50 value 
of the formulated tablets were also satisfactory. In fine, 
further investigation is required to establish in-vivo-in-
vitro correlation to manifest the exact pattern of drug 
release in-vivo condition from this polymeric system. 
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